MedTrace Logo

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib

NCT01725230 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2013-02-04

No results posted yet for this study

Summary

A study to Assess the Pharmacokinetics of Rosuvastatin and Simvastatin when administered alone or in combination with Fostamatinib.

Conditions

Interventions

DRUG

Fostamatinib

100-mg tablet

DRUG

Rosuvastatin

20-mg tablet

DRUG

Simvastatin

40-mg tablet

Sponsors & Collaborators

Principal Investigators

  • David Mathews, MD · Quintiles Phase I unit 6700 w 115th st Overland Park, Ks 66211

  • Christopher D O'Brien, MD PHD · AstraZeneca

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01725230 on ClinicalTrials.gov